Capitol Health Ltd
ASX:CAJ

Watchlist Manager
Capitol Health Ltd Logo
Capitol Health Ltd
ASX:CAJ
Watchlist
Price: 0.385 AUD Market Closed
Market Cap: 410.7m AUD
Have any thoughts about
Capitol Health Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one CAJ stock under the Base Case scenario is 0.755 AUD. Compared to the current market price of 0.385 AUD, Capitol Health Ltd is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAJ Relative Value
Base Case
0.755 AUD
Undervaluation 49%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
34
vs Industry
58
Median 3Y
1.6
Median 5Y
1.6
Industry
2.3
Forward
1.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
8
Median 3Y
23.9
Median 5Y
26.5
Industry
23.2
Forward
30.1
More Details
11.3
P/OCF
P/OCF
Price to OCF
11.3
vs History
1
vs Industry
37
Median 3Y
9.2
Median 5Y
8.5
Industry
14.3
More Details
16.9
P/FCFE
P/FCFE
Price to FCFE
16.9
vs History
28
vs Industry
25
Median 3Y
10.9
Median 5Y
10.9
Industry
20.1
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
0
vs Industry
36
Median 3Y
2.1
Median 5Y
2.1
Industry
2.2
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
22
vs Industry
50
Median 3Y
2.1
Median 5Y
2
Industry
2.4
Forward
2
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
25
vs Industry
68
Median 3Y
2.2
Median 5Y
2.2
Industry
5
More Details
330.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
330.3
vs History
0
vs Industry
12
Median 3Y
21.7
Median 5Y
20.5
Industry
12.8
Forward
9.4
More Details
330.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
330.3
vs History
0
vs Industry
18
Median 3Y
21.7
Median 5Y
20.5
Industry
17.2
Forward
19.2
More Details
14.3
EV/OCF
EV/OCF
Enterprise Value to OCF
14.3
vs History
9
vs Industry
32
Median 3Y
11.5
Median 5Y
10.7
Industry
14
More Details
30.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.1
vs History
15
vs Industry
12
Median 3Y
21.1
Median 5Y
19.3
Industry
18.2
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
0
vs Industry
45
Median 3Y
1.6
Median 5Y
1.4
Industry
1.9
More Details

Multiples Across Competitors

CAJ Competitors Multiples
Capitol Health Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Capitol Health Ltd
ASX:CAJ
409.1m AUD 1.7 -27.5 330.3 330.3
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1
P/E Multiple
Earnings Growth PEG
AU
Capitol Health Ltd
ASX:CAJ
Average P/E: 27
Negative Multiple: -27.5 		N/A N/A
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
Cigna Corp
NYSE:CI
25.6
25%
1
US
CVS Health Corp
NYSE:CVS
11.2
3%
3.7
DE
Fresenius Medical Care AG
XMUN:FME
49
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.3
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.4
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.5
31%
0.8
US
DaVita Inc
NYSE:DVA
15.4
17%
0.9

See Also

Summary
CAJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAJ stock valuation using valuation multiples.
Wall Street Estimates
CAJ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.